Nall Infection Treatment Holds Promise

September 2014
MMR;9/15/2014, Vol. 31 Issue 15, p17
Trade Publication
The article reports on the successful study of formulation to treat the onychomycosis fungal infections of the nail.


Related Articles

  • Practice Guidelines for the Management of Cryptococcal Disease. Saag, Michael S.; Graybill, Richard J.; Larsen, Robert A.; Pappas, Peter G.; Perfect, John R.; Powderly, William G.; Sobel, Jack D.; Dismukes, William E. // Clinical Infectious Diseases;4/1/2000, Vol. 30 Issue 4, p710 

    Executive Summary An 8-person subcommittee of the National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group evaluated available data on the treatment of cryptococcal disease. Opinion regarding optimal treatment was based on personal experience and information in the...

  • Practice Guidelines for the Management of Patients with Sporotrichosis. Kauffman, Carol A.; Hajjeh, Rana; Chapman, Stanley W. // Clinical Infectious Diseases;4/1/2000, Vol. 30 Issue 4, p684 

    Executive Summary The recommendations for the treatment of sporotrichosis were derived primarily from multicenter, nonrandomized treatment trials, small retrospective series, and case reports; no randomized, comparative treatment trials have been reported. Most cases of sporotrichosis are...

  • Spectrum of dermatophyte infections in Botswana. Thakur, Rameshwari // Clinical, Cosmetic & Investigational Dermatology;2015, Vol. 8, p127 

    Background: Dermatophyte infections are a common cause of superficial fungal infection in different geographical locations of the world. Usually, it involves superficial invasion of keratinized tissue, eg, skin, nails, and hair, but in immunosuppressed individuals, it may cause atypical,...

  • Reports on therapies and fungal infection from the 4th Conference on Retroviruses and...  // AIDS Patient Care & STDs;Apr97, Vol. 11 Issue 2, p100 

    Reports on research findings during the 4th Conference on Retroviruses and Opportunistic Infections. Oral therapy for cryptococcal meningitis; Fluconazole resistance and cyclodextrin.

  • Treatment of Iatrogenic Fungal Infections: A Black Mold Defines a New Gray Zone in Medicine. Shoham, Shmuel; Marr, Kieren A. // Annals of Internal Medicine;2/5/2013, Vol. 158 Issue 3, p208 

    The article presents questions and answers related to treatment of iatrogenic fungal infections including clinicians' approach for persons exposed to contaminated methylprednisolone acetate, treatment of presumed or documented fungal infection, and understanding of unknowns.

  • Onychomycosis: Current Trends in Diagnosis and Treatment. WESTERBERG, DYANNE P.; VOYACK, MICHAEL J. // American Family Physician;12/1/2013, Vol. 88 Issue 11, p762 

    Onychomycosis is a fungal infection of the nails that causes discoloration, thickening, and separation from the nail bed. Onychomycosis occurs in 10% of the general population, 20% of persons older than 60 years, and 50% of those older than 70 years. It is caused by a variety of organisms, but...

  • Toxic hepatitis during ketoconazole treatment. Heiberg, Jens K.; Svejgaard, Else // British Medical Journal (Clinical Research Edition);9/26/1981, Vol. 283 Issue 6295, p825 

    Examines the side effects of ketoconazole, an oral broad-spectrum antimycotic drug for the treatment of systemic fungal infections. Identification of liver toxicity by increasing serum enzyme activities; Detection of enlarged portal tracts with mononuclear cell infiltration; Capability to...

  • How Many Steps along the Path Is Too Far? Drusano, G. L. // Clinical Infectious Diseases;1/1/2010, Vol. 50 Issue 1, p37 

    The author reflects on the study conducted by M. Neely and colleagues regarding the disposition of voriconazole in children diagnosed or suspected having a fungal infection. He argues that the study was retrospective as other have also reported relationships between voriconazole measurements and...

  • Practice Guidelines for Diseases Caused by Aspergillus. Stevens, David A.; Kan, Virginia L.; Judson, Marc A.; Morrison, Vicki A.; Dummer, Stephen; Denning, David W.; Bennett, John E.; Walsh, Thomas J.; Patterson, Thomas F.; Pankey, George A. // Clinical Infectious Diseases;4/1/2000, Vol. 30 Issue 4, p696 

    Executive Summary Aspergillosis comprises a variety of manifestations of infection. These guidelines are directed to 3 principal entities: invasive aspergillosis, involving several organ systems (particularly pulmonary disease); pulmonary aspergilloma; and allergic bronchopulmonary...

  • Inhaled Amphotericin B as Fungal Prophylaxis in Heart Transplant Recipients. WILDE, ASHLEY M.; NAILOR, MICHAEL D. // Connecticut Medicine;Nov2011, Vol. 75 Issue 10, p613 

    The article explores the use of inhaled amphotericin B as a fungal prophylaxis for heart transplant patients with invasive fungal disease. It cites reoperation and post-transplant dialysis as risk factors for IFD in these patients. There are several disadvantages associated with amphotericin B...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics